Drug Database
Back to search

Netherlands· NL-fd0b0c52635c

Micrazym 10.000 eenheden, harde maagsapresistente capsules

A multienzyme - lipase, protease etc product containing amylase + lipase + pancreatine + protease, registered in Netherlands by All-Gen Pharmaceuticals & Generics B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC A09AA02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedMicrazym 10.000 eenheden, harde maags…ATCA09AA02REGISTER NO.NL-fd0b0c52635cPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about amylase + lipase + pancreatine + proteaseAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Multienzyme - lipase, protease etc is registered in 11 of 19 countries.

Countries holding a registration under ATC A09AA02 (multienzyme - lipase, protease etc), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search multienzyme - lipase, protease etc products by name

Multienzyme - lipase, protease etc · ATC A09AA02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
AMYLASE + LIPASE + PANCREATINE + PROTEASE
Manufacturer
All-Gen Pharmaceuticals & Generics B.V.
Country
Netherlands (NL)
ATC code
A09AA02
ATC class
Multienzyme - Lipase, Protease etc
Defined daily dose
240 TSD, FIP
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    127060

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

20 interactions on record for multienzyme - lipase, protease etc.

Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check multienzyme - lipase, protease etc against other medicinesHow interaction checks work

Multienzyme - lipase, protease etc · interactions on record

20 records

  • 20 moderate

Most severe, free to view

  • Magnesium hydroxideA02AA04moderate
  • Kombinationen von AluminiumsalzenA02AB10moderate
  • Calcium carbonateA02AC01moderate
  • MagaldrateA02AD02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under A09AA02

Multienzyme - lipase, protease etc, as other registers publish it.

All multienzyme - lipase, protease etc products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d353976a-6514-42f7-ae67-e5c2908b8cba
GET /v1/drugs/d353976a-6514-42f7-ae67-e5c2908b8cba?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Maagsapresistente capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h127060_smpc.pdf",
  "strength": null,
  "atc_label": "Multienzymes (Lipase, Protease Etc.)",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg127060",
  "excipients": [
    "BUTYLHYDROXYTOLUEEN (E 321)",
    "CETYLALCOHOL",
    "CHINOLINEGEEL (E 104)",
    "COPOLYMEER VAN ETHYLACRYLAAT-METHACRYLZUUR (1:1)",
    "GELATINE (E 441)",
    "MACROGOL 4000",
    "METHYLCELLULOSE (E 461)",
    "NATRIUMLAURILSULFAAT",
    "PATENTBLAUW V (E 131)",
    "POLOXAMEER 407",
    "POLYSORBAAT 80 (E 433)",
    "PONCEAU 4R (E 124)",
    "SIMETICON",
    "SORBINEZUUR (E 200)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "AMYLASE",
    "LIPASE",
    "PANCREATINE",
    "PROTEASE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h127060.pdf",
  "authorised_at": "2024/09/18",
  "procedure_number": "NL/H/5258/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "127060",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about multienzyme - lipase, protease etc.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console